Quality of Life Among Urban Hypertensive Patients
Quality of Life Among Urban Hypertensive Patients
Quality of Life Among Urban Hypertensive Patients
Tran Nguyen Ngoc1, Dang Thanh Tung2, Bui Van Dung3, Trinh Viet Anh4, Bui Van San1, Hoang Thi
Phuong Nam3, Nguyen Hoang Thanh1, Huy Dinh Quang5, Thien Van Tran6
1
Department of Psychiatry, Hanoi Medical University, Hanoi, Vietnam
2
National Institute of Mental Health, Bach Mai Hospital, Hanoi, Vietnam
3
Department of Cardiovascular and Respiratory, Geriatric Hospital, Hanoi, Vietnam
4
Department of Respiratory, E Hospital, Hanoi, Vietnam
5
School of Preventive and Public Health, Hanoi Medical University, Hanoi, Vietnam
6
Department of General Planning & Quality Management, Vietnam National University, Hanoi, Vietnam
Corresponding Author:
Dang Thanh Tung
National Institute of Mental Health, Bach Mai Hospital
Hanoi, Vietnam
Email: tungdangthanh@bachmai.edu.vn
1. INTRODUCTION
Hypertension is well-recognized as a significant risk factor for several major non-communicable
diseases (e.g., cardiovascular diseases, diabetes, renal, or nerve diseases) as well as a predictor of early
premature mortality [1], [2]. In 2010, high blood pressure was attributable to approximately 7.5 million deaths,
which accounted for 12.8% of all-cause mortality worldwide [3]. There was estimated that close to 1.13 billion
people had been diagnosed with hypertension in 2015 [2], which is predicted to reach 1.56 billion in 2025 [4],
[5]. In Vietnam, hypertension is an emerging problem in the adult population as a consequence of the rapid
growth of the aging population, urbanization, and unhealthy lifestyles [6], [7]. The prevalence of hypertension
in Vietnamese adults ranges from 18.4 to 21.1% [6], which is responsible for 11.1% of the disease burden in
2017 [8]. However, only 9.3% of hypertensive patients are aware of their condition, 4.7% received appropriate
treatment [6], and 12.2% of patients have well-controlled hypertension [9].
As hypertension is a chronic condition that cannot be completely cured, quality of life (QOL) is an
important indicator to measure the effectiveness of hypertension treatment and management [10]. Several
previous studies have affirmed that hypertension significantly reduced patients’ QOL compared to those
without hypertension [11], [12], especially in aspects of general health, physical functioning, vitality, and
mental health [13]. Predictors for the poor QOL in hypertensive patients included socioeconomic status (e.g.,
female, higher age, lower education, lower income, living in the rural area) [14], [15], and clinical
characteristics (e.g., polypharmacy, complications or co-morbidities, adverse effect form anti-hypertensive
medications) [15]–[17]. These factors vary depending on study settings, suggesting the need for contextualized
evidence for improving QOL in hypertensive patients.
Despite the importance of QOL assessment in hypertensive patients, studies on this issue in Vietnam
are insufficient. To date, only two studies were performed in the mountainous hospital setting using Short-form
36v2 [18] and in a rural community setting using The World Health Organization Quality of Life Brief Version
WHOQOL-BREF [19]. Both studies showed a moderate-low QOL of hypertensive patients in comparison with
the general population. This study investigated the QOL of hypertensive patients in an urban setting and
evaluate related factors.
2. METHOD
2.1. Study design
We obtained the cross-sectional data at an outpatient department of an urban hospital in Hanoi,
Vietnam in October 2019. More than 100 hypertensive patients visited this department per day for regular
examination. Patients who were aged 18 years or above, had high blood pressure which was diagnosed based
on the Ministry of Health’s criteria [20] at least one year and did not have any psychological or cognitive
disorders were included in the study. Patients who were inpatients or disagreed to become study participants
were excluded. We applied a convenient sampling method. During the data collection period, among 250
patients who were invited, 220 individuals agreed to participate in the study response rate 88%. The study and
data collection tool were approved by the institution review board of the hospital. All participants were
informed and signed the written informed consent form.
Int J Public Health Sci, Vol. 12, No. 3, September 2023: 981-988
Int J Public Health Sci ISSN: 2252-8806 983
Clinical characteristics and health status are shown in Table 2. The majority of participants were
controlled hypertensive patients 59.6%. The proportion of patients experiencing lipid disorders as a
comorbidity was the highest at 40.9%, followed by bone-joint diseases 40.5%, heart diseases 27.7%, and
diabetes 22.3%. The mean number of medications per person was 1.6 (SD=1.1), and the mean body mass index
was 23.7 (SD=2.7kg/m2).
In controlled hypertensive patients, the mean PCS-12 score, and MCS-12 score were 43.3 (SD=7.9)
and 56.3 (SD=6.5), respectively. In uncontrolled hypertensive patients, the corresponding values were 43.3
(SD=9.2) and 56.1 (SD=9.1), respectively. Results of Table 3 show that no difference was found in SF-12
domain scores and component summary scores between controlled and uncontrolled hypertensive patients
(p>0.05).
The findings of this study indicated that the QOL of adults with hypertension had moderate scores in
all SF-12 aspects, particularly general health. The physical and mental component summary scores in our
sample can be comparable to the sample of Vietnamese older women in the previous study, who are among
the most vulnerable population to chronic diseases [23]. Unfortunately, we could not find any literature about
HRQOL measured by SF-12 or Short-form 36 in the general Vietnamese population for comparison. However,
compared to studies in other countries such as South Korea [24] and China [25], which had a similar culture to
Vietnam, we found that the HRQOL in our patients equaled half of the QOL of general people living in these
countries. Our finding in the MCS-12 score was higher, but our PCS-12 score was lower than MCS-12 and
PCS-12 in Brazilian hypertensive patients, respectively [26]. The difference could be explained by several
reasons such as different socio-economic and clinical characteristics or differences of QOL perceptions across
nations. However, these findings suggested the significant HRQOL impairment of hypertensive patients in
comparison with the general population.
After adjusting to other covariates, we found that higher age was associated with a lower PCS-12
score (Coef. = -0.17, 95% C=-0.31; -0.02). People living in low-population density areas have a higher MCS-
12 score (Coef. =3.22, 95% Ci=0.15; 6.30) than those living in high-population density areas. Increasing one
comorbidity and one medication reduced 1.09 points of PCS score (Coef. =-1.09, 95%CI=-1.87; -0.31) and
1.47 points of PCS score (Coef. = -1.47, 95%Ci=-2.52; -0.43), respectively. Meanwhile, a one kg/m2 increase
was related to a 0.51-point increase in the MCS score (Coef. =0.51, 95%CI=0.11; 0.91). Finally, patients
participating in social activity had a 3.02 MCS-12 score higher than those not participating (Coef. =3.02;
95%CI=0.78; 5.27) as shown in Table 4.
Advancing age, the higher number of comorbidities, and medications used were associated with the
decrease in QOL regarding physical perspective. These results were similar to prior works in Vietnam and
Int J Public Health Sci, Vol. 12, No. 3, September 2023: 981-988
Int J Public Health Sci ISSN: 2252-8806 985
other countries [18], [27], [28]. Notably, hypertensive patients participating in social activities had a higher
MCS score than those who did not. Indeed, most of our sample were aged 60 or above and were legally retired.
Literature underlined the fact that increasing the independence or autonomy of older people via facilitating
social participation or providing job opportunities would also improve their quality of life [27], [29].
Furthermore, patients who lived in the low population-density area (such as suburban or rural places) had
higher MCS scores than individuals living in the high-density area (such as the urban part of Hanoi), which
aligned with previous findings in the general population that urban people were more likely to experience
mental problems compared to rural ones, leading to the reduction of MCS score [27].
Finally, we did not find any association between hypertension condition and HRQOL. This finding
was in line with the previous study in Vietnam [18], but different from a study in Nigeria [30] and China [14].
We supposed that these phenomena might be due to methodological and cultural differences. Studies in Nigeria
used blood pressure as a continuous variable while our study used a binary variable. Moreover, we did not
measure patients’ medication adherence, which might be a potential confounder for this association.
Several major limitations should be acknowledged. First, the validity and reliability of SF-12v2 in the
Vietnamese population in general and hypertensive patients, in particular, are unknown. Despite its
pervasiveness in other Asian countries such as Korea and China [24], [25], further studies should be required
to elucidate this issue. Second, data were acquired via face-to-face interviews, which might be at risk of recall
bias. Third, we used the cross-sectional design which was not appropriate for drawing causal associations
between QOL and its related factors. Finally, the finding should be cautious when applied to other settings
because of the sampling process.
4. CONCLUSION
This study found a moderate level of QOL in hypertensive patients regardless of treatment progress.
Age, living area, comorbidities, medications used, and social participation are critical factors associated with
the QOL of hypertensive patients. Regular screening and controlling comorbidities, as well as motivating active
employment and social activities involvement, are the potential to enhance the QOL of this population.
REFERENCES
[1] N. Bui Van et al., “Prevalence and risk factors of hypertension in the Vietnamese elderly,” High Blood Pressure and Cardiovascular
Prevention, vol. 26, no. 3, pp. 239–246, 2019, doi: 10.1007/s40292-019-00314-8.
[2] WHO, “Hypertension,” 2019. https://www.who.int/news-room/fact-sheets/detail/hypertension?fbclid=IwAR1z8jUo-
8_fZO2Oapx8SUppeF6RdZLv8y9rbimTBmq5gsAIpvWmAhq6L90 (accessed Oct. 11, 2019).
[3] WHO, “Global status report on noncommunicable diseases 2010 Geneva, Switzerland,” World Health, 2010.
http://whqlibdoc.who.int/publications/2011/9789240686458_eng.pdf.
[4] M. Joffres et al., “Hypertension prevalence, awareness, treatment and control in national surveys from England, the USA and
Canada, and correlation with stroke and ischaemic heart disease mortality: A cross-sectional study,” BMJ Open, vol. 3, no. 8, p.
e003423, 2013, doi: 10.1136/bmjopen-2013-003423.
[5] P. M. Kearney, M. Whelton, K. Reynolds, P. Muntner, P. K. Whelton, and J. He, “Global burden of hypertension: analysis of
worldwide data,” The Lancet, vol. 365, no. 9455, pp. 217–223, 2005, doi: 10.1016/s0140-6736(05)17741-1.
[6] L. Meiqari, D. Essink, P. Wright, and F. Scheele, “Prevalence of hypertension in Vietnam: A systematic review and meta-analysis,”
Asia-Pacific Journal of Public Health, vol. 31, no. 2, pp. 101–112, 2019, doi: 10.1177/1010539518824810.
[7] A. M. Sarki, C. U. Nduka, S. Stranges, N. B. Kandala, and O. A. Uthman, “Prevalence of hypertension in low- and middle-income
countries: A systematic review and meta-analysis,” Medicine (United States), vol. 94, no. 50, p. e1959, 2015, doi:
10.1097/MD.0000000000001959.
[8] J. D. Stanaway et al., “Global, regional, and national comparative risk assessment of 84 behavioural, environmental and
occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990-2017: A systematic analysis for the
Global Burden of Disease Stu,” The Lancet, vol. 392, no. 10159, pp. 1923–1994, 2018, doi: 10.1016/S0140-6736(18)32225-6.
[9] H. A. Hien, N. M. Tam, V. Tam, A. Derese, and D. Devroey, “Prevalence, Awareness, Treatment, and control of hypertension and
its risk factors in (Central) Vietnam,” International Journal of Hypertension, vol. 2018, pp. 1–12, 2018, doi: 10.1155/2018/6326984.
[10] N. T. Ha, H. T. Duy, N. H. Le, V. Khanal, and R. Moorin, “Quality of life among people living with hypertension in a rural Vietnam
community,” BMC Public Health, vol. 14, no. 1, p. 833, 2014, doi: 10.1186/1471-2458-14-833.
[11] S. Ghimire, P. Pradhananga, B. K. Baral, and N. Shrestha, “Factors associated with health-related quality of life among hypertensive
patients in Kathmandu, Nepal,” Frontiers in Cardiovascular Medicine, vol. 4, Nov. 2017, doi: 10.3389/fcvm.2017.00069.
[12] S. G. Sazlina, A. Zaiton, M. Z. Nor Afiah, and K. S. Hayati, “Predictors of health related quality of life in older people with non-
communicable diseases attending three primary care clinics in malaysia,” Journal of Nutrition, Health and Aging, vol. 16, no. 5,
pp. 498–502, 2012, doi: 10.1007/s12603-012-0038-8.
[13] F. J. Mena-Martin, J. C. Martin-Escudero, F. Simal-Blanco, J. L. Carretero-Ares, D. Arzua-Mouronte, and V. Herreros-Fernandez,
“Health-related quality of life of subjects with known and unknown hypertension: Results from the population-based Hortega
study,” Journal of Hypertension, vol. 21, no. 7, pp. 1283–1289, 2003, doi: 10.1097/00004872-200307000-00015.
[14] L. Zhang et al., “Health-related quality of life among adults with and without hypertension: A population-based survey using EQ-
5D in Shandong, China,” Scientific Reports, vol. 7, no. 1, p. 14960, 2017, doi: 10.1038/s41598-017-15083-4.
[15] V. Katsi et al., “Arterial hypertension and health-related quality of life,” Frontiers in Psychiatry, vol. 8, no. DEC, 2017, doi:
10.3389/fpsyt.2017.00270.
[16] A. C. C. de Souza, J. W. P. Borges, and T. M. M. Moreira, “Quality of life and treatment adherence in hypertensive patients:
Systematic review with meta-analysis,” Revista de Saude Publica, vol. 50, 2016, doi: 10.1590/S1518-8787.2016050006415.
[17] A. Al-Mandhari, I. Al-Zakwani, A. Al-Hasn, and N. Al-Sumri, “Assessment of perceived health status in hypertensive and diabetes
mellitus patients at primary health centers in Oman,” International Journal of Preventive Medicine, vol. 2, no. 4, pp. 256–263, 2011.
[18] T. P. L. Nguyen, P. F. M. Krabbe, T. B. Y. Nguyen, C. C. M. Schuiling-Veninga, E. P. Wright, and M. J. Postma, “Utilities of
patients with hypertension in Northern Vietnam,” PLoS ONE, vol. 10, no. 10, p. e0139560, 2015, doi:
10.1371/journal.pone.0139560.
[19] N. T. Ha, H. T. Duy, N. H. Le, V. Khanal, and R. Moorin, “Quality of life among people living with hypertension in a rural Vietnam
community (double),” BMC Public Health, vol. 14, no. 1, p. 833, 2014, doi: 10.1186/1471-2458-14-833.
[20] V. M. of Health, Decision 3192/QD-BYT in 2010 issuing guidance on measuring and treatment hypertension. 2010.
[21] D. Turner-Bowker and S. J. Hogue, “Short form 12 health survey (SF-12),” in Encyclopedia of Quality of Life and Well-Being
Research, 2014, pp. 5954–5957, doi: 10.1007/978-94-007-0753-5_2698.
[22] J. Ware, M. Kosinski, and S. Keller, “How to Score SF-12,” SF-12 v2: How to Score Version 2 of the SF-12 Health Survey, no.
January 2002, pp. 29–38, 1995.
[23] T. H. Dao-Tran, C. Seib, L. Jones, and D. Anderson, “A cross-cultural comparison of health-related quality of life and its associated
factors among older women in Vietnam and Australia,” BMC Research Notes, vol. 11, no. 1, p. 174, 2018, doi: 10.1186/s13104-
018-3282-0.
[24] S. H. Kim, M. W. Jo, J. Ahn, M. Ock, S. Shin, and J. Park, “Assessment of psychometric properties of the Korean SF-12 v2 in the
general population,” BMC Public Health, vol. 14, no. 1, p. 1086, 2014, doi: 10.1186/1471-2458-14-1086.
[25] X. Xu, Y. Rao, Z. Shi, L. Liu, C. Chen, and Y. Zhao, “Hypertension impact on health-related quality of life: A cross-sectional
survey among middle-aged adults in Chongqing, China,” International Journal of Hypertension, vol. 2016, pp. 1–7, 2016, doi:
10.1155/2016/7404957.
[26] D. J. Trevisol, L. B. Moreira, F. D. Fuchs, and S. C. Fuchs, “Health-related quality of life is worse in individuals with hypertension
under drug treatment: Results of population-based study,” Journal of Human Hypertension, vol. 26, no. 6, pp. 374–380, 2012, doi:
10.1038/jhh.2011.48.
[27] L. H. Nguyen, B. X. Tran, Q. N. Hoang Le, T. T. Tran, and C. A. Latkin, “Quality of life profile of general Vietnamese population
using EQ-5D-5L,” Health and Quality of Life Outcomes, vol. 15, no. 1, p. 199, 2017, doi: 10.1186/s12955-017-0771-0.
[28] T. Van Nguyen, H. Van Nguyen, T. Duc Nguyen, T. Van Nguyen, and P. The Nguyen, “Difference in quality of life and associated
factors among the elderly in rural Vietnam,” Journal of Preventive Medicine and Hygiene, vol. 58, no. 1, pp. E63–E71, 2017, doi:
10.15167/2421-4248/jpmh2017.58.1.655.
[29] N. T. Huong, L. T. H. Ha, and T. Q. Tien, “Determinants of health-related quality of life among elderly: evidence from Chi Linh
Town, Vietnam,” Asia-Pacific Journal of Public Health, vol. 29, no. 5_suppl, pp. 84S-93S, 2017, doi: 10.1177/1010539517704041.
[30] A. D. A. Adedapo, O. O. Akunne, and B. O. Adedokun, “Comparative assessment of determinants of health-related quality of life
in hypertensive patients and normal population in south-west Nigeria,” International Journal of Clinical Pharmacology and
Therapeutics, vol. 53, no. 3, pp. 265–271, 2015, doi: 10.5414/CP202257.
Int J Public Health Sci, Vol. 12, No. 3, September 2023: 981-988
Int J Public Health Sci ISSN: 2252-8806 987
BIOGRAPHIES OF AUTHORS
Bui Van Dung is a medical doctor and researcher in National Geriatric Hospital,
Hanoi, Vietnam. His expertise focused on the health of older people. He has published many
articles in quality of life at older people. He can be contacted at email:
dungtmvlk@gmail.com.
Trinh Viet Anh is a medical doctor and researcher at E Hospital, Hanoi. His
expertise is respiratory disease. He has published many articles in the areas of quality of life
and mental health. He can be contacted at email: vaphuong34@gmail.com.
Bui Van San is a lecturer and researcher at Hanoi Medical University, Hanoi,
Vietnam. His expertise focused on mental health. He has published many articles in the areas
of quality of life and mental health. He can be contacted at email: buivansan@hmu.edu.vn.
Hoang Thi Phuong Nam is a medical doctor and researcher in National Geriatric
Hospital, Hanoi, Vietnam. Her expertise focused on the health of older people. She has
published many articles in quality of life at older people. She can be contacted at email:
hoangthiphuongnam@hmu.edu.vn.
Huy Dinh Quang is a radiologist and has extensive experience in the field of
medical management. He is currently working at the Department of General Planning and
Quality Management, Vietnam National University Hospital. He is interested in measures
and processes to support expertise and maximize work efficiency. He can be contacted at
email: dinhquanghuy@vnu.edu.vn.
Thien Tran Van is an expert in the field of Public Health, and a person with
extensive experience in the field of health management. Currently, he is the Deputy Director
of Vietnam National University Hospital. He is interested in measures and processes to
support expertise and maximize work efficiency. He can be contacted at email:
thientv.vnuh@gmail.com.
Int J Public Health Sci, Vol. 12, No. 3, September 2023: 981-988